How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bioresorbable (Resorbable) Polymers Market
- By Polymer Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polycaprolactone (PCL), Poly(lactic-co-glycolic acid) (PLGA), Polyhydroxyalkanoates (PHA)
- By Application: Orthopedic Devices, Surgical Sutures, Drug Delivery Systems, Tissue Engineering, Cardiovascular Devices
- By Form: Films and Sheets, Fibers and Threads, Injectable Microspheres, Implants and Scaffolds, Hydrogels
- By End-Use Industry: Medical, Pharmaceutical, Agriculture, Packaging, Environmental Biodegradable Products
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Polylactic Acid (PLA) leads By Polymer Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Bioresorbable (Resorbable) Polymers Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Polymer Type 5
Application 5
Form 5
End-Use Industry 5
Companies profiled
Evonik Industries AG
Corbion N.V.
BASF SE
Mitsubishi Chemical Holdings Corporation
NatureWorks LLC
Shandong Freda Biochem Co. Ltd.
Gujarat Fluorochemicals Limited
Unitika Ltd.
Heraeus Holding GmbH
Poly-Med Inc.
Teijin Limited
CordenPharma International GmbH
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Corbion N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mitsubishi Chemical Holdings Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →NatureWorks LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Shandong Freda Biochem Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Gujarat Fluorochemicals Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Unitika Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Heraeus Holding GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Poly-Med Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Teijin Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →CordenPharma International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Luye Pharma Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Wacker Chemie AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sino Biopharmaceutical Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$10,378M by 2033 · 10.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Polylactic Acid (PLA)51.2
- Polyglycolic Acid (PGA)12.7
- Polycaprolactone (PCL)14.1
- Poly(lactic-co-glycolic acid) (PLGA)10.9
- Polyhydroxyalkanoates (PHA)11.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,537M → $3,525M · 10.9%
Europe$1,072M → $2,264M · 9.8%
Asia Pacific$978.4M → $2,421M · 12.0%
Latin America$605.7M → $1,500M · 12.0%
Middle East and Africa$465.9M → $937.6M · 9.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.492026
10.492027
10.512028
10.512029
10.542030
10.552031
10.552032
10.572033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Evonik Industries AG17.5
- Corbion N.V.16.2
- BASF SE11.3
- Mitsubishi Chemical Holdings Corporation11.6
- NatureWorks LLC5.0
- Shandong Freda Biochem Co. Ltd.10.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Polymer Type13.6%
Application37.8%
Form35.1%
End-Use Industry13.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.1
- Europe21.3
- Asia Pacific22.7
- Latin America14.1
- Middle East and Africa8.8
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Evonik Industries AG | 84 | 77 | 76 | 95 | 88 | 85 | 84 |
| Corbion N.V. | 77 | 71 | 84 | 78 | 74 | 87 | 79 |
| BASF SE | 63 | 77 | 70 | 66 | 79 | 81 | 73 |
| Mitsubishi Chemical Holdings Corporation | 75 | 82 | 69 | 59 | 58 | 68 | 69 |
| NatureWorks LLC | 57 | 59 | 51 | 65 | 58 | 58 | 58 |
| Shandong Freda Biochem Co. Ltd. | 60 | 61 | 62 | 55 | 68 | 62 | 61 |
| Gujarat Fluorochemicals Limited | 55 | 49 | 61 | 59 | 54 | 42 | 53 |
| Unitika Ltd. | 42 | 55 | 44 | 54 | 47 | 38 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Evonik Industries AG
- Corbion N.V.
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Evonik Industries AG | ✓ | ◐ | ◐ | ◐ | ✓ | ✓ |
| Corbion N.V. | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| BASF SE | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Mitsubishi Chemical Holdings Corporation | ✓ | ◐ | ◐ | − | − | ◐ |
| NatureWorks LLC | ◐ | − | ◐ | ◐ | ◐ | − |
| Shandong Freda Biochem Co. Ltd. | ◐ | − | ◐ | − | ✓ | − |
| Gujarat Fluorochemicals Limited | − | − | ◐ | − | ◐ | − |
| Unitika Ltd. | − | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Evonik Industries AG84
2Corbion N.V.79
3BASF SE73
4Mitsubishi Chemical Holdings Corporation69
5Shandong Freda Biochem Co. Ltd.61
6NatureWorks LLC58
7Gujarat Fluorochemicals Limited53
8Unitika Ltd.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Evonik Industries AGCorbion N.V.
Challenger2
Strong scale, closing on the leaders.
BASF SEMitsubishi Chemical Holdings Corporation
Contender2
Focused players with pockets of strength.
NatureWorks LLCShandong Freda Biochem Co. Ltd.
Niche2
Specialists in a single segment or region.
Gujarat Fluorochemicals LimitedUnitika Ltd.
Go-to-market strategy
Land Polymer Type in North America, then scale across Bioresorbable (Resorbable) Polymers Market — a $285M beachhead inside a $4.26B market.
Beachhead (SOM)$285Mobtainable near-term
Serviceable (SAM)$1.74Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Polylactic Acid (PLA)
Best fit — highest urgency & budget in Polymer Type.
Economic buyer80 fit
Polyglycolic Acid (PGA)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Polycaprolactone (PCL)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Polymer Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Polymer Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bioresorbable (Resorbable) Polymers Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation15%
Closed-won6%
$21.6KCAC
$106KLTV
4.9:1LTV : CAC
< 5 moCAC payback
Investment thesis
Bioresorbable (Resorbable) Polymers Market is a high-growth opportunity — $1.33B by 2033, compounding at 10.8%.
TAM · 2025$589Mtoday
TAM · 2033$1.33Bforecast
CAGR10.8%2027–2033
Cumulative$8.25Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.33BTotal addressable market
SAM$486MServiceable available market
SOM$82MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.8% CAGR
Demand compounds through 2033, outpacing GDP across Polymer Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Polymer Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.33BLarge & growingTAM by 2033 at 10.8% CAGR
$486MServiceable nowreachable with today’s model
$82MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.04BBear7.0% CAGR
$1.33BBase10.8% CAGR
$1.71BBull14.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bioresorbable (Resorbable) Polymers Market — a $9.08B market by 2033. Plan: grow share from 5.3% to 11.4%.
Market size · 2033$9.08Btotal addressable
Market CAGR9.4%2027–2033
Target share11.4%from 5.3% today
Revenue ambition$1.04Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.3% | 11.4% | Ahead |
| Revenue | $496M | $1.04B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 38.0% | 40.8% | At risk |
| Customer retention | 84.5% | 95.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Polymer Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Polymer Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $137M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Polymer Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Bioresorbable (Resorbable) Polymers Market conversation — a $927M market you can size, segment and defend in minutes.
Market size · 2033$927Mtotal opportunity
Growth5.8%CAGR to 2033
Addressable buyers1,620+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Polymer Type
Goal Grow share in Polymer Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$74K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Evonik Industries AGCorbion N.V.BASF SEMitsubishi Chemical Holdings CorporationNatureWorks LLCShandong Freda Biochem Co. Ltd.Gujarat Fluorochemicals LimitedUnitika Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bioresorbable (Resorbable) Polymers Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bioresorbable (Resorbable) Polymers Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bio-Resorbable Ceramic Market
Market size, share, segmentation and regional forecast.
$407M market · 2025 base year
View reportBio-Resorbable Pins and Screw Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportBioresorbable Polymer Market
Market size, share, segmentation and regional forecast.
$942M market · 2025 base year
View reportBIOS Firmware Technology Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBio-Safe Hand-Washing Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBiosafety Testing Services for Biologics BPO Service Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportBiosecurity Type Sterilizer Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportBiosensor For Non-Clinical Applications Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBiosensors and Nanosensors Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBiosensors in Life Sciences Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportBioseparation Devices Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBioseparation System Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.